SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-068987
Filing Date
2024-08-14
Accepted
2024-08-14 16:05:28
Documents
73
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0211041-10q_longeveron.htm   iXBRL 10-Q 1028617
2 CERTIFICATION ea0211041ex31-1_longeveron.htm EX-31.1 11806
3 CERTIFICATION ea0211041ex31-2_longeveron.htm EX-31.2 11864
4 CERTIFICATION ea0211041ex32-1_longeveron.htm EX-32.1 6123
10 GRAPHIC image_001.jpg GRAPHIC 1568
11 GRAPHIC image_002.jpg GRAPHIC 1535
12 GRAPHIC image_003.jpg GRAPHIC 1597
  Complete submission text file 0001213900-24-068987.txt   5421624

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE lgvn-20240630.xsd EX-101.SCH 44525
6 XBRL CALCULATION FILE lgvn-20240630_cal.xml EX-101.CAL 39081
7 XBRL DEFINITION FILE lgvn-20240630_def.xml EX-101.DEF 268054
8 XBRL LABEL FILE lgvn-20240630_lab.xml EX-101.LAB 443313
9 XBRL PRESENTATION FILE lgvn-20240630_pre.xml EX-101.PRE 270458
76 EXTRACTED XBRL INSTANCE DOCUMENT ea0211041-10q_longeveron_htm.xml XML 541638
Mailing Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136
Business Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136 305-302-7158
Longeveron Inc. (Filer) CIK: 0001721484 (see all company filings)

IRS No.: 472174146 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40060 | Film No.: 241207495
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)